Ethyl 2-((5-bromo-3-nitropyridin-2-yl)oxy)acetate

Introduction

CAS No. :	105544-30-7	MDL No. :	MFCD01648643
Formula :	C9H9BrN2O5	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	UHIILDDDMFTHKM-UHFFFAOYSA-N
M.W :	305.08	Pubchem ID :	4647502
Synonyms :

Physicochemical Properties

Num. heavy atoms :	17
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.33
Num. rotatable bonds :	6
Num. H-bond acceptors :	6.0
Num. H-bond donors :	0.0
Molar Refractivity :	62.96
TPSA :	94.24 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	No
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	Yes
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-6.77 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.98
Log Po/w (XLOGP3) :	1.96
Log Po/w (WLOGP) :	1.69
Log Po/w (MLOGP) :	0.28
Log Po/w (SILICOS-IT) :	0.04
Consensus Log Po/w :	1.19

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-2.83
Solubility :	0.45 mg/ml ; 0.00147 mol/l
Class :	Soluble
Log S (Ali) :	-3.56
Solubility :	0.0832 mg/ml ; 0.000273 mol/l
Class :	Soluble
Log S (SILICOS-IT) :	-2.87
Solubility :	0.411 mg/ml ; 0.00135 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	2.0 alert
Leadlikeness :	0.0
Synthetic accessibility :	2.69

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine